Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-13-001300
Filing Date
2013-03-18
Accepted
2013-03-18 16:53:34
Documents
13
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ptx_10k.htm 10-K 2092641
2 EXHIBIT 10.14 ptx_ex1014.htm EX-10.14 69195
3 SUBSIDIARIES ptx_ex211.htm EX-21.1 4069
4 CONSENT ptx_ex231.htm EX-23.1 4599
5 CERTIFICATION ptx_ex311.htm EX-31.1 12182
6 CERTIFICATION ptx_ex312.htm EX-31.2 12047
7 CERTIFICATION ptx_ex321.htm EX-32.1 9607
  Complete submission text file 0001354488-13-001300.txt   8949447

Data Files

Seq Description Document Type Size
8 ptx-20121231.xml EX-101.INS 1169672
9 ptx-20121231.xsd EX-101.SCH 61510
10 ptx-20121231_cal.xml EX-101.CAL 68461
11 ptx-20121231_lab.xml EX-101.LAB 476457
12 ptx-20121231_pre.xml EX-101.PRE 355664
13 ptx-20121231_def.xml EX-101.DEF 143273
Mailing Address 33219 FOREST WEST STREET MAGNOLIA TX 77354
Business Address 33219 FOREST WEST STREET MAGNOLIA TX 77354 (832) 934-1825
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

EIN.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14494 | Film No.: 13698318
SIC: 2834 Pharmaceutical Preparations